Stay updated on Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's revision tag was updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a small metadata update to the page.
    Difference
    0.0%
    Check dated 2026-08-13T01:37:25.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page footer now displays the revision tag updated from v3.6.3 to v3.6.4, signaling a newer version of the page. This is a routine maintenance update with no substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-22T13:53:48.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing Revision: v3.6.0. This indicates an internal update to the page or its documents rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-07-01T02:36:37.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    New user-guidance sections were added and recruitment status updated to No longer looking for participants; the Intervention/Treatment heading is standardized and a Revision: v3.6.0 tag is introduced while the old v3.5.5 tag is removed.
    Difference
    0.1%
    Check dated 2026-06-16T18:35:16.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This likely reflects minor updates to layout or metadata, while the core study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-09T14:48:08.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Updated the Ukraine location entries to use Kharkiv Oblast and Kharkiv, Kharkiv Oblast, Ukraine, 61024 instead of the previous Kharkivs’ka Oblast’ naming.
    Difference
    0.0%
    Check dated 2026-06-02T14:01:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.